| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
1 company
Giacobello Scott M. is a Chief Financial Officer at WHWK. Recent filings cover 0 purchases and 4 sales. Those positions are worth an estimated $1.3M at current prices.
Our model assigns Giacobello Scott M. a below-average insider score of 33/100, based on 4 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -44.3%.
Giacobello Scott M.'s largest disclosed position is in WHWK as Chief Financial Officer, worth about $1.3M. The recent filings there lean toward selling, a net 224,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | WHWK Whitehawk Therapeutics, Inc. | Chief Financial Officer | Sell | 218,600 | $4.03 | $882,028.00 | -42.5% | -9.0% | - | |
| Mar 2, 2026 | WHWK Whitehawk Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 2,594 | $3.31 | $8,585.10 | -8.5% | +37.3% | - | |
| Mar 3, 2025 | WHWK Whitehawk Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 2,806 | $2.35 | $6,594.10 | -10.5% | -24.3% | +44.3% |